Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masatoshi Kudo

Showing results (1-10 of 1,326) with videos related to

Pageof 133
Sort By:
Oncology|July 10, 2010
Management of hepatocellular carcinoma: from prevention to molecular targeted therapyMasatoshi Kudo
Journal of Gastroenterology|January 17, 2009
Multistep human hepatocarcinogenesis: correlation of imaging with pathologyMasatoshi Kudo
Liver Cancer|October 16, 2018
Proposal of Primary Endpoints for TACE Combination Trials with Systemic Therapy: Lessons Learned from 5 Negative Trials and the Positive TACTICS TrialMasatoshi Kudo
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|January 11, 2019
[Systemic therapy for hepatocellular carcinoma:recent advances and future perspective]Masatoshi Kudo
Hepatobiliary Surgery and Nutrition|August 25, 2021
Lack of response to immunotherapy in non-alcoholic steatohepatitis related hepatocellular carcinomaMasatoshi Kudo
Liver Cancer|August 18, 2022
Selection of Systemic Treatment Regimen for Unresectable Hepatocellular Carcinoma: Does Etiology Matter?Masatoshi Kudo
Intervirology|September 24, 2004
Atypical large well-differentiated hepatocellular carcinoma with benign nature: a new clinical entityMasatoshi Kudo
Liver Cancer|June 14, 2019
Pembrolizumab for the Treatment of Hepatocellular CarcinomaMasatoshi Kudo
Liver Cancer|October 12, 2019
Immuno-Oncology Therapy for Hepatocellular Carcinoma: Current Status and Ongoing TrialsMasatoshi Kudo
Liver Cancer|February 28, 2022
Newly Developed Modified ALBI Grade Shows Better Prognostic and Predictive Value for Hepatocellular CarcinomaMasatoshi Kudo
Pageof 133

Showing results (1-10 of 1,326) with videos related to

Sort By:
Pageof 133
Oncology|July 10, 2010
Management of hepatocellular carcinoma: from prevention to molecular targeted therapyMasatoshi Kudo
Journal of Gastroenterology|January 17, 2009
Multistep human hepatocarcinogenesis: correlation of imaging with pathologyMasatoshi Kudo
Liver Cancer|October 16, 2018
Proposal of Primary Endpoints for TACE Combination Trials with Systemic Therapy: Lessons Learned from 5 Negative Trials and the Positive TACTICS TrialMasatoshi Kudo
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|January 11, 2019
[Systemic therapy for hepatocellular carcinoma:recent advances and future perspective]Masatoshi Kudo
Hepatobiliary Surgery and Nutrition|August 25, 2021
Lack of response to immunotherapy in non-alcoholic steatohepatitis related hepatocellular carcinomaMasatoshi Kudo
Liver Cancer|August 18, 2022
Selection of Systemic Treatment Regimen for Unresectable Hepatocellular Carcinoma: Does Etiology Matter?Masatoshi Kudo
Intervirology|September 24, 2004
Atypical large well-differentiated hepatocellular carcinoma with benign nature: a new clinical entityMasatoshi Kudo
Liver Cancer|June 14, 2019
Pembrolizumab for the Treatment of Hepatocellular CarcinomaMasatoshi Kudo
Liver Cancer|October 12, 2019
Immuno-Oncology Therapy for Hepatocellular Carcinoma: Current Status and Ongoing TrialsMasatoshi Kudo
Liver Cancer|February 28, 2022
Newly Developed Modified ALBI Grade Shows Better Prognostic and Predictive Value for Hepatocellular CarcinomaMasatoshi Kudo
Pageof 133